Follow the development
ALGINAGRAFT™ is not for sale and there is no order form. There are three reasons to write, and each has its own short form. Messages go to the author, who replies personally. No list, no newsletter, no automated sequence.
Get notified when something changes
One email when bench data are posted, a regulatory step is completed, or a publication appears. Nothing else, and never more often than the facts change.
Describe a case
Where does particulate graft come out in your hands — an open socket, a sinus window, a vertical augmentation, under a provisional? The scenarios clinicians describe shape what is tested first. No patient data, please; the situation, not the patient.
Register interest in a future evaluation
If and when a clinical evaluation is planned, it will be announced on the development status page first. Registering interest here means you will hear about it when there is something to hear. No timeline is promised, and registering creates no obligation on either side.
For licensing and general company matters, see meddentinnovativeconcepts.com.